Skip to main content

Highlights

  1. 1
    Journal of medicinal chemistry · 2022
    PMID: 36346696PMCID: PMC9866367DOISenior author23 citations
  2. 2
    ACS medicinal chemistry letters · 2021
    PMID: 34413957PMCID: PMC8366019DOISenior author22 citations

Publications

97 publications

Funding

4 grants

Active

3 grants
  • Co-I
    Advancing an ADCY10 inhibitor on-demand male contraceptive into humans
    Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2026–2030
    P50HD123367-01
  • Co-I
    Optimization of lead candidates for an on-demand male contraceptive
    Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2023–2028
    R01HD111549-01A1
  • Co-I
    On-demand nonhormonal male contraception via ADCY10 inhibition
    Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2023–2026
    P50HD113015-01
Completed grants (1)
  • Co-I
    On-Demand Pharmacological Contraception by Blocking ADCY 10
    Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2019–2022
    P50HD100549-03

News mentions

External relationships

Leadership Roles

Meinke Pharma Consulting, LLC · Sacyl Pharmaceuticals, Inc.

Ownership

FemFort Contraception LLC · Meinke Pharma Consulting, LLC · Sacyl Pharmaceuticals, Inc.

Proprietary Interest

Sacyl Pharmaceuticals, Inc.